Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML).

Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML). Blood. 2009 Aug 27; 114(9):1736-45.

View in: PubMed

subject areas

Adult
Cell Line, Tumor
Disease-Free Survival
Female
Granulocyte-Macrophage Colony-Stimulating Factor
Humans
Immunotherapy
Leukemia, Myeloid, Acute
Male
Middle Aged
Remission Induction
Stem Cell Transplantation
Transplantation, Autologous
Treatment Outcome

authors with profiles

Wendy Stock